NOX provides update to Nyrada Note Holders
December 18 Nyrada Update
Noxopharm Releases Report on Key Progress of Subsidiary Nyrada
Noxopharm Subsidiary Nyrada Announces Important Drug Discovery
AFR 30 August 2018 : Advances in Biotech - Lower cholesterol treatment breakthrough
Nyrada- key progress with cholesterol-lowering drug candidate
Nyrada, Inc. Newsletter 2. April 2018
Nyrada,Inc. Newsletter 1. Jan/Feb 2018
Noxopharm Closes $4M Capital Raising for its US Subsidiary, Nyrada,Inc.
Identification of NYX-104, a promising lead candidate for the treatment of stroke and other excitotoxicity- associated disorders.

1 2 Next
  Subscribe to Email Alerts